GlassScriptPhysician profile
Sumona V Smith
NPI 1750566493
$1,709.87
in general payments reported to CMS, 2019-2025
23 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.90 · 2020: $72.31 · 2021: $140 · 2022: $683 · 2023: $478 · 2024: $82.14 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $302.87 | 2021-2023 | Auryon Laser System 100-120 Vac |
| Lemaitre Vascular, INC. | $249.29 | 2022 | |
| Medtronic, INC. | $240.58 | 2021-2025 | Venaseal, Closurefast |
| Janssen Pharmaceuticals, INC | $176.46 | 2021-2023 | Xarelto |
| Polynovo North America LLC | $107.74 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $86.31 | 2024-2025 | Verquvo, Winrevair, Capvaxive |
| Inari Medical, INC. | $66.43 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $54.75 | 2019-2022 | |
| Pfizer INC. | $51.73 | 2024-2025 | |
| Shockwave Medical, INC | $44.28 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $42.30 | 2021-2025 | Juxtapid |
| Tactile Systems Technology INC | $40.33 | 2020 | |
| Bridgebio Pharma, INC. | $33.65 | 2025 | Attruby |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.39 | 2024 | Jardiance |
| Medtronic Vascular, INC. | $31.98 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $29.02 | 2025 | |
| Acacia Pharma INC | $25.35 | 2022 | |
| Cardiva Medical, INC. | $18.78 | 2022 | |
| Novo Nordisk INC | $18.07 | 2025 | Wegovy |
| Silk Road Medical, INC. | $16.82 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.27 | 2021 | |
| Aroa Biosurgery Incorporated | $13.92 | 2022 | |
| Integra Lifesciences Corporation | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumona Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.